Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Nanobiotix soars as late-phase cancer trial hits endpoint

fiercebiotechJune 25, 2018

Tag: Nanobiotix , late-phase cancer , endpoint

PharmaSources Customer Service